Tauriga Sciences, Inc. Completes Package Design for its Tauri-Gummies Product
December 23 2019 - 8:00AM
InvestorsHub NewsWire
Tauriga Sciences, Inc. Completes Package Design for its
Tauri-Gummies Product
NEW YORK, NY --
December 23, 2019 -- InvestorsHub NewsWire -- Tauriga
Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a
revenue generating Company that operates through the development,
distribution, and licensing of proprietary products as well as the
evaluation of potential acquisition opportunities and equity
investments, today announced that it has completed the package
design for its Tauri-Gummies™ product; plant based “pectin”
CBD Isolate infused gum drops (cherry, orange, lime, and lemon
flavors) – NO GELATIN. On December 6, 2019, the Company
announced that it had completed its initial Tauri-Gummies™
production run and that the concentration of CBD Isolate was
increased from 15mg to 25mg per each Vegan Gum Drop and from 360mg
to 600mg per each Tauri-Gummies™ Jar (“Jar”). This
initial Tauri-Gummies™ production run yielded an inventory of
1,000 Jars (24,000 Gum Drops). The Company expects that
its Tauri-Gummies™ product will be available to the retail
marketplace, within the next few weeks. The anticipated
Manufacturer’s Suggested Retail Price (“MSRP”) has been set at
$24.99 per Jar.
The Company is
pleased to confirm that its Tauri-Gummies™ packaging is
Environmentally Friendly – with recyclable plastic(s) being used at
all times. Lastly, the Company will obtain its Kosher
Certification (Authority: Star-K) prior to launching this product
to the retail marketplace; the Company is hopeful to achieve this
within the next several
days.
ABOUT TAURIGA
SCIENCES INC.
Tauriga Sciences,
Inc. (TAUG) is a revenue generating Company that operates through
the development, distribution, and licensing of proprietary
products as well as the evaluation of potential acquisition
opportunities. One such opportunity on which the Company has acted,
involves the Company having entered into the cannabidiol (or “CBD”)
infused chewing gum product business, as more fully described above
and in prior press releases. This CBD infused chewing gum
product has been branded under the following name:
Tauri-Gum™. The Company is currently in production of
three distinct flavors of Tauri-Gum™: MINT, BLOOD ORANGE, and
POMEGRANATE. On December 6, 2019 the Company announced
that it completed the initial production run (thereby expanding its
existing product lines) with the introduction of a 25mg Vegan CBD
Isolate Infused vegan gummy (“gum drop”), branded under the name:
Tauri-Gummies™. Further, the Company continues to
identify and evaluate additional potential opportunities to
generate revenue, as well as shareholder value, and leverage its
resources and expertise to build a diversified and sustainable
business model. Please visit our corporate website
at www.tauriga.com.
In addition, on
March 11, 2019, the Company announced the official launch of its
E-Commerce site - as part of its Tauri-Gum™ commercialization
strategy. This site can be accessed by visiting the following
URL
address: www.taurigum.com
The Company has
established corporate offices in both New York City (USA) and
Barcelona (Spain).
DISCLAIMER --
Forward-Looking Statements
This press release
contains certain “forward-looking statements” as defined by the
Private Securities Litigation Reform Act of 1995 which represent
management’s beliefs and assumptions concerning future events.
These forward-looking statements are often indicated by using words
such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,”
“believes,” or plans, and may include statements regarding
corporate objectives as well as the attainment of certain corporate
goals and milestones. Forward-looking statements are based on
present circumstances and on management’s present beliefs with
respect to events that have not occurred, that may not occur, or
that may occur with different consequences or timing than those now
assumed or anticipated. Actual results may differ materially from
those expressed in forward looking statements due to
known and unknown risks and uncertainties, such as are not
guarantees of general economic and business conditions, the ability
to successfully develop and market products, consumer and business
consumption habits, the ability to consummate successful
acquisition and licensing transactions, fluctuations in exchange
rates, and other factors over which Tauriga has little or no
control. Many of these risks and uncertainties are discussed in
greater detail in the “Risk Factors” section of Tauriga’s Form 10-K
and other filings made from time to time with the Securities and
Exchange Commission. Such forward-looking statements are made only
as of the date of this release, and Tauriga assumes no obligation
to update forward-looking statements to reflect subsequent events
or circumstances. You should not place undue reliance on these
forward-looking statements.
Contact:
CONTACT
INFORMATION
Tauriga Sciences,
Inc.
555 Madison Avenue, 5th Floor
New York, NY 10022
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
cell # (917) 796 9926
Corp. Website: www.tauriga.com
E-Commerce
Website: www.taurigum.com
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Sep 2023 to Sep 2024